Indian Kanoon - Search engine for Indian Law

placed significant reliance on expert testimony of two kinds - first, on X-ray diffraction tests which establish that Tarceva is Polymorph B alone and second

details of the specification of the aforementioned patent or the x-ray diffraction of the product (tablet) Tarceva or the defendant‟s Erlocip was indicated ... purchased some manufactured in August 2006 from the local market. The x-ray diffraction data of Tarceva sold in India showed that

Astrazeneca Ab & Ors vs P Kumar & Anr on 8 August, 2019 Equivalent citations

Court could have relied on evidence of use of the X-Ray diffraction technique and a consequential analysis of the peaks of both to ascertain ... Erlotinib Hydrochloride. By focusing on evidence involving the analysis of X-Ray diffraction data, the Learned Single Judge has erroneously compared the products of Roche

form of Differential Scanning Calorimetry (DSC)10, Thermogravimetric Analysis11 (TGA) or X-Ray Diffraction (XRD) of Glenmark‟s products. This would have indicated that

submission that the plaintiff was bound to disclose the X-ray diffraction pattern of the claims in the suit patent and of Ceritinib was also ... Rules 1 and 2 of the CPC , the Court cannot examine X-ray diffraction patterns. (xii) The reliance of the defendant on the fact that

powder X-ray diffraction pattern. It 0 is described that it is characterized by having peaks at diffraction angles (2θ) near ... X-Ray Diffusion Pattern can be measured by a Usual method. Further, the value of the diffusion angle of the powder X-ray diffraction

infringed. The plaintiffs will also have to disclose to Court the x-ray diffraction data of the product, particularly if it is a pharmaceutical drug ... entire specification of the patent held by the plaintiff together with X-ray diffraction data of Tarceva and Erlocip filed along with the plaint

following Formula c28: [Formula c28] wherein the crystalline form has an X-ray diffraction (XRD) spectrum which includes peaks at diffraction angles

F. Hoffmann-La Roche Ltd, Switzerland ... vs Cipla Ltd., Mumbai Central, Mumbai on 7 September